464 results on '"Taft, Ryan J"'
Search Results
2. Advancing access to genome sequencing for rare genetic disorders: recent progress and call to action
3. Evidence review and considerations for use of first line genome sequencing to diagnose rare genetic disorders
4. The impact of clinical genome sequencing in a global population with suspected rare genetic disease
5. The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change
6. Development of a comprehensive genome-wide cardiovascular disease genetic risk assessment test
7. Pathogenic variants in USP7 cause a neurodevelopmental disorder with speech delays, altered behavior, and neurologic anomalies
8. Novel mutations in the mitochondrial complex I assembly gene NDUFAF5 reveal heterogeneous phenotypes
9. Clinical whole genome sequencing as a first-tier test at a resource-limited dysmorphology clinic in Mexico
10. Heterozygous WNT1 variant causing a variable bone phenotype
11. Best practices for the interpretation and reporting of clinical whole genome sequencing
12. Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study
13. Mutations in PIGS, Encoding a GPI Transamidase, Cause a Neurological Syndrome Ranging from Fetal Akinesia to Epileptic Encephalopathy
14. Congenital sodium diarrhea and chorioretinal coloboma with optic disc coloboma in a patient with biallelic SPINT2 mutations, including p.(Tyr163Cys)
15. Fatal Perinatal Mitochondrial Cardiac Failure Caused by Recurrent De Novo Duplications in the ATAD3 Locus
16. Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data
17. Publisher Correction: Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data
18. The diagnostic trajectory of infants and children with clinical features of genetic disease
19. TUBB4A de novo mutations cause isolated hypomyelination
20. Genome sequencing detects a balanced pericentric inversion with breakpoints that impact the DMD and upstream region of POU3F4 genes.
21. The smallest likely pathogenic duplication of a SOX9 enhancer identified to date in a family with 46,XX testicular differences of sex development
22. Estimating the burden and economic impact of pediatric genetic disease
23. Microdeletions excluding YWHAE and PAFAH1B1 cause a unique leukoencephalopathy: further delineation of the 17p13.3 microdeletion spectrum
24. ExpansionHunter Denovo: a computational method for locating known and novel repeat expansions in short-read sequencing data
25. Leukoencephalopathy due to variants in GFPT1-associated congenital myasthenic syndrome
26. Supplementary Figures 1 - 5 from MicroRNAs Regulate Tumor Angiogenesis Modulated by Endothelial Progenitor Cells
27. Supplementary Methods and Figure Legend from MicroRNAs Regulate Tumor Angiogenesis Modulated by Endothelial Progenitor Cells
28. Data from MicroRNAs Regulate Tumor Angiogenesis Modulated by Endothelial Progenitor Cells
29. Supplementary Figures 9 - 10 from MicroRNAs Regulate Tumor Angiogenesis Modulated by Endothelial Progenitor Cells
30. Supplementary Figure 11 from MicroRNAs Regulate Tumor Angiogenesis Modulated by Endothelial Progenitor Cells
31. Supplementary Figures 6 - 8 from MicroRNAs Regulate Tumor Angiogenesis Modulated by Endothelial Progenitor Cells
32. Supplementary Tables 1 - 8 from MicroRNAs Regulate Tumor Angiogenesis Modulated by Endothelial Progenitor Cells
33. Reactive gene curation to support interpretation and reporting of a clinical genome test for rare disease: Experience from over 1,000 cases
34. Biallelic variants in LARS2 and KARS cause deafness and (ovario)leukodystrophy
35. Diverse RNA interference strategies in early-branching metazoans
36. X-linked hypomyelination with spondylometaphyseal dysplasia (H-SMD) associated with mutations in AIFM1
37. Optimized deep-targeted proteotranscriptomic profiling reveals unexplored Conus toxin diversity and novel cysteine frameworks
38. Reactive gene curation to support interpretation and reporting of a clinical genome test for rare disease: Experience from over 1,000 cases
39. The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change
40. HeterozygousNOTCH1Variants Cause CNS Immune Activation and Microangiopathy
41. Inactivation of AMMECR1 is associated with growth, bone, and heart alterations
42. A recurrent de novo mutation in TMEM106B causes hypomyelinating leukodystrophy
43. PERCHING syndrome: Clinical presentation in the first African patient confirmed by clinical whole genome sequencing
44. Correction: Estimating the burden and economic impact of pediatric genetic disease
45. Further Considerations on the Value of Whole-Genome Sequencing in Critically Ill Infants—Reply
46. A clinical laboratory's experience using GeneMatcher—Building stronger gene–disease relationships
47. Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study
48. De Novo ATP1A1 Variants in an Early-Onset Complex Neurodevelopmental Syndrome
49. Genome sequencing identifies three molecular diagnoses including a mosaic variant in the COL2A1 gene in an individual with Pol III-related leukodystrophy and Feingold syndrome
50. Whole Exome Sequencing in Patients with White Matter Abnormalities
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.